Trexquant Investment LP Akebia Therapeutics, Inc. Transaction History

Trexquant Investment LP

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 07, 2020	SELL	$6.67 - $13.58 $616,234 - $1.25 Million	-92,389 Closed	0 $0
Q1 2020 May 08, 2020	BUY	$4.1 - $10.24 $378,794 - $946,063	92,389 New	92,389 $700,000
Q1 2019 May 13, 2019	SELL	$5.41 - $8.73 $295,348 - $476,596	-54,593 Closed	0 $0
Q4 2018 Feb 13, 2019	BUY	$5.39 - $9.15 $294,256 - $499,525	54,593 New	54,593 $302,000
Q3 2018 Nov 09, 2018	SELL	$7.44 - $10.65 $266,515 - $381,504	-35,822 Closed	0 $0
Q2 2018 Aug 07, 2018	BUY	$9.15 - $11.34 $327,771 - $406,221	35,822 New	35,822 $358,000
Q1 2018 May 03, 2018	SELL	$9.53 - $15.68 $201,102 - $330,879	-21,102 Closed	0 $0
Q4 2017 Feb 09, 2018	BUY	$14.24 - $19.59 $49,783 - $68,486	3,496 Added 19.86%	21,102 $314,000
Q3 2017 Nov 09, 2017	BUY	$13.06 - $19.67 $229,934 - $346,310	17,606	17,606 $346,000

120

54.8M

291K

179K

Ticker AKBA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 183,848,992
Market Cap $324M
Description
Akebia Therapeutics, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics for patients with kidney diseases. The company's lead product investigational product candidate is vadadustat, an oral therapy, which is in Phase III development for the treatment of anemia due to chronic kidney disease (CKD) ...

Get notified when there are updates to the investment portfolio of Trexquant Investment LP, based on Form 13F filings with the SEC.

Stay updated on Trexquant Investment LP with notifications on news.